1. Service de Médecine Interne 2, Institut E3M, Centre de Références des Maladies Auto-Immunes et Systémiques Rares, Centre de Référence des Histiocytoses, Hôpital de la Pitié-Salpêtrière, Assistance Publique–Hôpitaux de Paris (AP-HP), Université Pierre et Marie Curie, Paris, France;
2. Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY;
3. EA4340, Versailles University, Paris-Saclay University, Boulogne, France;
4. Pathology Service, Hôpital universitaire Ambroise Paré, AP-HP, Boulogne, France;
5. UMR1170, INSERM and Institute Gustave Roussy, Villejuif, France;
6. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH;
7. Department of Pathology,
8. Department of Radiology, and
9. Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY;
10. Department of Internal Medicine, Foch Hospital, Suresnes, France;
11. Department of Internal Medicine, Croix Saint-Simon Hospital, Paris, France;
12. Department of Internal Medicine and Immunology, and
13. Department of Biological Hematology, University Hospital La Pitié Salpêtrière, AP-HP, Paris, France;
14. Gustave Roussy, Paris-Saclay University, Genomic Platform UMS AMMICA, Villejuif, France; and
15. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY